AbbVie Inc (LTS:0QCV)
$ 177.49 1.52 (0.88%) Market Cap: 318.09 Bil Enterprise Value: 381.92 Bil PE Ratio: 62.50 PB Ratio: 52.72 GF Score: 85/100

Abbvie Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 08:45PM GMT
Release Date Price: $136.57 (+0.04%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing AbbVie today at the 40th Annual JPMorgan Healthcare Conference.

From the company, we're going to have a presentation from Rob Michael, the CFO; and we'll have Mike Severino, President of AbbVie; and Jeff Stewart, Chief Commercial Officer, joining us for the Q&A.

So Rob, Mike, Jeff, Happy New Year. Thanks for joining us, and I look forward to the presentation.

Robert A. Michael
AbbVie Inc. - Vice Chairman of Finance & Commercial Operations and CFO

Great. So thank you, Chris, and good afternoon, everyone. It's a pleasure to be here today. Before I begin, please take a moment to review our forward-looking statements on Slide 2.

Turning to Slide 3. Since AbbVie's inception, we have developed and assembled a broad portfolio of diversified growth assets with leadership positions across several attractive markets, including immunology, hematologic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot